What folic acid dose should be prescribed for a patient on weekly methotrexate, and for women of child‑bearing potential planning pregnancy?

Folic Acid Dosing for Methotrexate and Pregnancy Planning

Prescribe at least 5 mg of folic acid per week for patients on weekly methotrexate therapy, and 0.4-0.8 mg (400-800 mcg) daily for women of childbearing potential planning pregnancy.

For Patients on Weekly Methotrexate

The standard recommendation is at least 5 mg folic acid per week 1. This dose has Grade A evidence (highest level) from multinational rheumatology guidelines and significantly reduces methotrexate toxicity without compromising efficacy 1.

Dosing Options for Methotrexate Patients:

• Standard approach: 5 mg folic acid once weekly, taken the day after methotrexate administration 2
• Alternative approach: 1-1.25 mg folic acid daily (provides similar or better protection) 1, 3
• Higher doses: Up to 5 mg daily can be used if toxicity persists, though doses above 5 mg weekly may theoretically reduce methotrexate efficacy 4

The evidence strongly supports that folic acid supplementation:

• Reduces gastrointestinal side effects (nausea, vomiting) by approximately 29% 1
• Decreases hepatotoxicity risk by 83% 1
• Improves medication adherence by reducing withdrawal rates by 71% 1
• Does not reduce methotrexate's therapeutic effectiveness 2, 5, 6

Important Caveat:

Use folic acid, not folinic acid (leucovorin), unless specifically indicated. While folinic acid at doses >5 mg/week may reduce side effects, it can also reduce methotrexate efficacy 1. Folic acid is preferred, more cost-effective, and equally protective 7.

For Women Planning Pregnancy

Prescribe 0.4-0.8 mg (400-800 mcg) of folic acid daily for all women of childbearing potential who could become pregnant 8, 9.

Critical Timing:

• Begin supplementation at least 1 month before conception and continue through early pregnancy 8
• Since >50% of pregnancies are unplanned, women should take folic acid continuously throughout their reproductive years 8
• This prevents neural tube defects, which occur within the first month after conception, often before pregnancy is recognized 8

Dosing by Risk Category:

Standard risk (most women): 0.4-0.8 mg (400-800 mcg) daily 8, 9

Higher risk groups (previous neural tube defect, family history): 4-5 mg daily 10

Critical Safety Warning:

Methotrexate must be discontinued at least 3 months before attempting pregnancy in both men and women 1, 4, 1, 11. Methotrexate is highly teratogenic and causes major birth defects when taken during pregnancy 11. Women must use effective contraception while on methotrexate 4.

Practical Implementation Algorithm:

For methotrexate patients:

1. Start 5 mg folic acid weekly (day after methotrexate) OR 1 mg daily
2. If GI symptoms or elevated liver enzymes persist → increase to 5 mg daily
3. Monitor liver function tests every 1-3 months 1
4. Do not exceed 1 mg daily total folate intake from all sources to avoid masking B12 deficiency 8

For pregnancy planning:

1. Verify patient is taking 0.4-0.8 mg folic acid daily
2. If on methotrexate → stop methotrexate immediately and wait 3 months minimum 1, 11
3. Continue folic acid 0.4-0.8 mg daily throughout pregnancy attempt and first trimester
4. Increase to 4-5 mg daily only if high-risk factors present 10

Common Pitfall:

Do not confuse the two indications—methotrexate patients need 5 mg weekly (or 1 mg daily) for toxicity prevention, while pregnancy planning requires 0.4-0.8 mg daily for neural tube defect prevention. These are separate, non-overlapping indications with different dosing rationales.